Seralutinib for the Treatment of Pulmonary Arterial Hypertension (PAH): Results From the Phase 2 TORREY Trial

被引：0

作者：

Frantz, R. P. ^{[1
]}

McLaughlin, V. V. ^{[2
]}

Sahay, S. ^{[3
]}

Subias, P. Escribano ^{[4
]}

Zolty, R. L. ^{[5
]}

Benza, R. L. ^{[6
]}

Channick, R. N. ^{[7
]}

Chin, K. M. ^{[8
]}

Hemnes, A. R. ^{[9
]}

Howard, L. S. ^{[10
]}

Sitbon, O. ^{[11
]}

Vachiery, J. ^{[12
]}

Zamanian, R. T. ^{[13
]}

Cravets, M. ^{[14
]}

Roscigno, R. F. ^{[15
]}

Mottola, D. ^{[15
]}

Elman, E. ^{[16
]}

Parsley, E. ^{[15
]}

Aranda, R. ^{[17
]}

Zisman, L. S. ^{[15
]}

Ghofrani, H. ^{[18
]}

机构：

[1] Mayo Clin, Cardiovasc Med, Rochester, MN USA

[2] Univ Michigan, Cardiovasc Dis, Internal Med, Ann Arbor, MI USA

[3] Houston Methodist Hosp Weill Cornell Med, Div Pulm Crit Care & Sleep Med, Houston, TX USA

[4] Univ Complutense, Univ Hosp Octubre 12, Cardiol, Madrid, Spain

[5] Univ Nebraska Med Ctr, Internal Med, Omaha, NE USA

[6] Ohio State Univ, Wexner Med Ctr, Div Cardiovasc Dis, Columbus, OH USA

[7] UCLA Med Ctr, Pulmonol, Crit Care Med, Los Angeles, CA USA

[8] UT Southwestern Med Ctr, Internal Med, Dallas, TX USA

[9] Vanderbilt Univ, Dept Med, Nashville, TN USA

[10] Imperial Coll Healthcare NHS Trust, Cardiol, London, England

[11] Univ Paris Saclay, Hop Bicetre, Serv Pneumol, Le Kremlin Bicetre, France

[12] HUB Hop Erasme, Cardiol, Brussels, Belgium

[13] Stanford Univ, Sch Med, Pulm & Crit Care Med, Stanford, CA USA

[14] Gossamer Bio Inc, Biometr, San Diego, CA USA

[15] Gossamer Bio Inc, Clin Dev, San Diego, CA USA

[16] Gossamer Bio Inc, Clin Operat, San Diego, CA USA

[17] Gossamer Bio Inc, Clin Execut, San Diego, CA USA

[18] Justus Liebig Univ Giessen, Dept Internal Med, Giessen, Germany

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A6726

引用

页数：2

共 50 条

[31] Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension (PAH): Results from INSPIRE Study
Hill, N. S.
Feldman, J. P.
Sahay, S.
Levine, D. J.
Patel, S.
Galloway, A.
Bull, T. M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[32] Effect of macitentan on left ventricular (LV) function in pulmonary arterial hypertension (PAH): results from REPAIR
Rosenkranz, S.
Channick, R.
Cottreel, E.
Galie, N.
Kiely, D. G.
Marcus, J. T.
Swift, A. J.
Tawakol, A.
Torbicki, A.
Noordegraaf, A. Vonk
Wetherill, G.
Peacock, A.
EUROPEAN HEART JOURNAL, 2020, 41 : 2296 - 2296
[33] PHYSICAL THERAPY IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH): RESULTS FROM A GERMAN CLAIMS DATA ANALYSIS
Barthuber, L.
Nill, I
Jacob, C.
Schmid, T.
VALUE IN HEALTH, 2024, 27 (12) : S334 - S334
[34] Riociguat for the Treatment of Pulmonary Arterial Hypertension (PAH): 1-Year Results from the PATENT-2 Long-term Extension Study
Rubin, Lewis
Galie, Nazzareno
Grimminger, Friedrich
Gruenig, Ekkehard
Humbert, Marc
Jing, Zhi-Cheng
Keogh, Anne
Langleben, David
Fritsch, Arno
Menezes, Flavia
Neuser, Dieter
Ghofrani, Hossein
CHEST, 2013, 144 (04)
[35] Sustained effect of seralutinib on circulating biomarkers: Lessons from the TORREY phase 2 open-label extension study
Osterhout, Robin
Hemnes, Anna R.
Sitbon, Olivier
Ghofrani, Hossein-Ardeschir
Benza, Raymond L.
Channick, Richard N.
Chin, Kelly M.
Frantz, Robert P.
Howard, Luke S.
V. Mclaughlin, Vallerie
Vachiery, Jean-Luc
Roscigno, Robert F.
Zisman, Lawrence S.
Aranda, Richard
Bruey, Jean-Marie
Zamanian, Roham T.
EUROPEAN RESPIRATORY JOURNAL, 2024, 64
[36] Psychometric Validation of the Pulmonary Arterial Hypertension- Symptoms and Impact (PAH-SYMPACT) Questionnaire Results of the SYMPHONY Trial
Chin, Kelly M.
Gomberg-Maitland, Mardi
Channick, Richard N.
Cuttica, Michael J.
Fischer, Aryeh
Frantz, Robert P.
Hunsche, Elke
Kleinman, Leah
McConnell, John W.
McLaughlin, Vallerie V.
Miller, Chad E.
Zamanian, Roham T.
Zastrow, Michael S.
Badesch, David B.
CHEST, 2018, 154 (04) : 848 - 861
[37] PULSAR open-label extension: interim results from a phase 2 study of the efficacy and safety of sotatercept when added to standard of care for the treatment of pulmonary arterial hypertension (PAH)
Badesch, David
Gibbs, Simon
Gomberg-Maitland, Mardi
Hoeper, Marius
Mclaughlin, Vallerie
Preston, Ioana
Souza, Rogerio
Waxman, Aaron
Manimaran, Solaiappan
Barnes, Jennifer
Pena, Janethe De Oliveira
Humbert, Marc
Hoeper, Marius M.
EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[38] Pulmonary Involvement in Systemic Sclerosis and Pulmonary Arterial Hypertension (PAH)
Graefenstein, K.
AKTUELLE RHEUMATOLOGIE, 2011, 36 (01) : 47 - 53
[39] Regional Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension (PAH)
Winkler, T.
Kohli, P.
Kelly, V. J.
Kehl, E. G.
Kone, M. T.
Hibbert, K.
Rodriguez-Lopez, J. M.
Systrom, D. M.
Waxman, A. B.
Venegas, J. G.
Channick, R. N.
Harris, R.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[40] COST-EFFECTIVENESS OF SELEXIPAG FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) IN GREECE
Solakidi, A.
Tzanetakos, C.
Beaudet, A.
Zervoudaki, A.
Lamprou, C.
Maniadakis, N.
VALUE IN HEALTH, 2017, 20 (09) : A645 - A645

← 1 2 3 4 5 →